close read more

Servier wishes you
a happy new year 2022

Read more

Servier - Independent international pharmaceutical laboratory

logo twitter


countries in which
the Group’s medicines
are distributed
23 %

of revenue from brand-name medicines invested in R&D in 2019/2020.

4.7 billion

euros in revenue in 2019/2020 comprising €3.3 billion for brand-name medicines and €1.4 billion for generic medicines.

4 therapeutic areas

cardiometabolism, neuroscience
and immuno-inflammation

icon play
icon play

Join our teams!

We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.

Understanding Companion Diagnostic Tests

They are the perfect illustration of the application of precision-based medicine for innovative patient care by helping to match a patient to a specific therapy.

Let’s Volunteer

The Servier Group’s employee engagement platform gathers all general interest missions proposed by the partner associations of the Mécénat Servier Charity Fund.

The basis for our actions

Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.

icon play